"If it was approved for aGVHD and my hospital had a stock of it, it wouldn't be in the drug cupboard."
"It would be kept in a specific place in the hospital"
"To use these medications for TGA approved reasons is even a hassle, often involving paperwork, consents, getting approval from pharmacy, getting approval from specialists, applying for approval through various associations, etc."
Quackery at its' best. Real doctors do not obsess over where a life-saving medicine is kept in the hospital. They also do no refer to gaining the relevant approvals for a life saving medication as a HASSLE. No real doctor would even mention these minor inconveniences (even in a Stock Forum).
Quite the opposite, real doctors will happily walk a few extra steps and fill out an extra form to Save a Child or Improve a Patients' Quality of Life. That is why we should see some level of off label use once Rem-L is approved for aGvHD (probably for Crohns etc where inflammation has also reaped havoc on the gut - as it does with aGvHD). But the real money will flow when we get full approval for said indications.
- Forums
- ASX - By Stock
- MSB
- MSB $1 Party
MSB $1 Party, page-476
-
- There are more pages in this discussion • 673 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
93.3¢ |
Change
0.048(5.37%) |
Mkt cap ! $1.061B |
Open | High | Low | Value | Volume |
88.5¢ | 95.0¢ | 88.0¢ | $3.254M | 3.540M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 11568 | 93.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
93.5¢ | 80326 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 24967 | 0.930 |
24 | 207273 | 0.925 |
20 | 226527 | 0.920 |
16 | 235649 | 0.915 |
12 | 691225 | 0.910 |
Price($) | Vol. | No. |
---|---|---|
0.935 | 32799 | 10 |
0.940 | 144566 | 14 |
0.945 | 172594 | 13 |
0.950 | 50389 | 10 |
0.955 | 23000 | 3 |
Last trade - 12.51pm 06/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |